+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030 - Product Thumbnail Image

Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030

  • Report
  • July 2021
  • 290 Pages
  • Global
From
Fc and Glycoengineered Antibodies Market: Industry Trends and Global Forecasts, till 2035: Distribution by Type of Engineering, Type of Therapy, Therapeutic Area, Route of Administration and Key Geographical Regions - Product Thumbnail Image

Fc and Glycoengineered Antibodies Market: Industry Trends and Global Forecasts, till 2035: Distribution by Type of Engineering, Type of Therapy, Therapeutic Area, Route of Administration and Key Geographical Regions

  • Report
  • April 2024
  • 293 Pages
  • Global
From
Allergic Rhinitis Drugs Market Report 2024-2034 - Product Thumbnail Image

Allergic Rhinitis Drugs Market Report 2024-2034

  • Report
  • February 2024
  • 322 Pages
  • Global
From
Allergy Immunotherapy Market Report 2023-2033 - Product Thumbnail Image

Allergy Immunotherapy Market Report 2023-2033

  • Report
  • May 2023
  • 187 Pages
  • Global
From
Biosimilar Monoclonal Antibodies Market Report 2022-2032 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies Market Report 2022-2032

  • Report
  • July 2022
  • 461 Pages
  • Global
From
TSLP Pipeline Review - Product Thumbnail Image

TSLP Pipeline Review

  • Report
  • May 2025
  • Global
From
Adalimumab (Humira) Biosimilars Pipeline Review - Product Thumbnail Image

Adalimumab (Humira) Biosimilars Pipeline Review

  • Report
  • May 2025
  • Global
From
Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry Perspective - Product Thumbnail Image

Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry Perspective

  • Report
  • October 2021
  • 433 Pages
  • Global
From
Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis Of Stakeholders, Technologies, Targets, Business and Financing from an Industry Perspective - Product Thumbnail Image

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis Of Stakeholders, Technologies, Targets, Business and Financing from an Industry Perspective

  • Report
  • July 2021
  • 259 Pages
  • Global
From
Global Systemic Lupus Erythematosus (SLE) Market (by Product Type, Route of Administration, End User, & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026) - Product Thumbnail Image

Global Systemic Lupus Erythematosus (SLE) Market (by Product Type, Route of Administration, End User, & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

  • Report
  • September 2023
  • 135 Pages
  • Global
From
China Bispecific Antibodies Market and Clinical Pipeline Insight 2028 - Product Thumbnail Image

China Bispecific Antibodies Market and Clinical Pipeline Insight 2028

  • Drug Pipelines
  • August 2023
  • 400 Pages
  • China
From
US Bispecific Antibodies Market & Clinical Pipeline Insight 2028 - Product Thumbnail Image

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

  • Drug Pipelines
  • August 2023
  • 580 Pages
  • United States
From
China Cancer Antibodies Market Trends & Clinical Trials Insight 2023 - Product Thumbnail Image

China Cancer Antibodies Market Trends & Clinical Trials Insight 2023

  • Report
  • May 2023
  • 1500 Pages
  • China
From
Global Leukemia Antibodies Market, Drug Sales & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Leukemia Antibodies Market, Drug Sales & Clinical Trials Insight 2028

  • Report
  • May 2022
  • 330 Pages
  • Global
From
Global Lung Cancer Antibodies Market, Drug Sales & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Lung Cancer Antibodies Market, Drug Sales & Clinical Trials Insight 2028

  • Report
  • May 2022
  • 510 Pages
  • Global
From
US Cancer Antibodies Market, Drug Sales, Patent & Clinical Trials Outlook 2028 - Product Thumbnail Image

US Cancer Antibodies Market, Drug Sales, Patent & Clinical Trials Outlook 2028

  • Report
  • February 2022
  • 360 Pages
  • United States
From
Global BiTE Antibodies Market , Price, Sales & Clinical Trials Insight 2025 - Product Thumbnail Image

Global BiTE Antibodies Market , Price, Sales & Clinical Trials Insight 2025

  • Report
  • February 2021
  • 100 Pages
  • Global
From
Global Tetraspecific Antibodies Clinical Trials & Market Opportunity Insight 2024 - Product Thumbnail Image

Global Tetraspecific Antibodies Clinical Trials & Market Opportunity Insight 2024

  • Report
  • May 2024
  • 100 Pages
  • Global
From
Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028 - Product Thumbnail Image

Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028

  • Report
  • October 2023
  • 470 Pages
  • Global
From
US Axial Spondyloarthritis Market outlook to 2028 - Product Thumbnail Image

US Axial Spondyloarthritis Market outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more